Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
10/2005
10/20/2005WO2005097761A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005WO2005097751A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097744A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity and the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005WO2005097136A1 Biaryl substituted pyrazinones as sodium channel blockers
10/20/2005WO2005066116A8 Disubstituted chalcone oximes as selective agonists of rarϝ retinoid receptors
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005WO2005034857A3 Methods and compositions comprising diamines as new anti-tubercular therapeutics
10/20/2005WO2005030794B1 Hemiasterlin derivatives and uses thereof
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234072 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, thus have a prolonged pharmacodynamic half-life
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234064 2-(4-Methoxyphenyl)-amino-),3-(aminocarbonyl-)quinoxaline; janus(JAK) kinase inhibitors;spleen tyrosine kinase(SYK) inhibitors; glycogen synthase-3(GSK-3) kinase inhibitors; immunocompetance; antiinflammatory agents; antiallergens; autoimmune diseases; antiproliferative agents; respiratory disorders
10/20/2005US20050234050 Ph sensitive prodrugs of 2,6-diisopropylphenol
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2560967A1 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (ne) and the serotonine (5-ht) activity andthe monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560966A1 Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms)
10/20/2005CA2560796A1 Biaryl substituted pyrazinones as sodium channel blockers
10/19/2005EP1586565A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
10/19/2005EP1585730A1 Carboxamide derivatives and their use as factor xa inhibitors
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
10/19/2005EP1423117B1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
10/19/2005EP1255740B1 Substituted arylpyrazines
10/19/2005CN1683346A Praziquantel synthetic process
10/19/2005CN1683345A Acid salt for synergistic medicine of chuanqiongzine and its preparing method
10/19/2005CN1223591C Piperazine oxime derivatives having Nk-1 receptor antagonistic activity
10/18/2005CA2240728C Kappa agonist compounds and pharmaceutical formulations thereof
10/18/2005CA2156288C Glycerol derivative, device and pharmaceutical composition
10/13/2005WO2005095361A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005021536A3 Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as dpp-iv inhibitors
10/13/2005US20050228182 e.g., N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-{4-[3-(1H-tetrazol-5-yl)propoxy]phenyl}butyl)guanidine hydrochloride; used to hydrate mucosal surfaces; are absorbed less rapidly, prolonged pharmacodynamic half-life; chronic bronchitis, cystic fibrosis, sinusitis, dry eye, mucus clearance
10/13/2005US20050228180 Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
10/13/2005US20050227999 Diarylamine derivatives as calcium channel blockers
10/13/2005US20050227997 Selective inhibition of aggrecanase in osteoarthritis treatment
10/13/2005US20050227995 Phenyl sulfoxides and phenyl sulfones
10/13/2005US20050227994 Decomposition inhibitor for extracellular matrix of cartilage
10/13/2005US20050227987 11beta-hydroxysteroid dehydrogenase inhibitors
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227335 From fluorescent pseudomonad bacterium, antifungal agent, antimicrobial agent
10/13/2005US20050224524 Aerosol
10/13/2005CA2562106A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583745A1 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
10/12/2005CN1681797A Process for producing oxycarbonyl-substituted piperazine derivative
10/12/2005CN1681498A Diaryl ethers as opioid receptor antagonist
10/12/2005CN1680373A Double piperazine quaternary ammonium salt compound with analgetic function
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/11/2005US6953792 Cyclohexyl derivatives and their use as therapeutic agents
10/06/2005WO2005092836A1 Opioid receptor antagonists
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222151 Non-Imidazole heterocyclic compounds
10/06/2005US20050222149 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
10/06/2005US20050222148 Phenylaminopropanol derivatives and methods of their use
10/06/2005US20050222142 1-(2,3-dihydro-4H-1,4-benzoxazin-4-yl)-3-(methylamino)-1-phenylpropan-2-ol; fluctuations of sex steroid lelels; monoamine reuptake modulator; antidepressant, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue and fibromylagia syndrome, stress and urinary incontinence
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005CA2557794A1 Opioid receptor antagonists
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005CN1678585A Therapeutic agents useful for treating pain
10/05/2005CN1221526C Novel phenyl-propargyl ether derivatives
10/04/2005US6951945 Heteroaromatic glucokinase activators
10/04/2005US6951872 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
10/04/2005US6951861 Chemical compounds
09/2005
09/29/2005WO2005090318A1 Novel amination process
09/29/2005US20050215691 Cationic alkoxyamines and their use in producing nano particles from natural or synthetic clays
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215563 Proteomimetic compounds and methods
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005CA2560790A1 Novel amination process
09/28/2005EP1578722A2 Kinase inhibitor scaffolds and methods for their preparation
09/28/2005CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675168A Propionic acid derivatives and their use as hPPARs activators
09/28/2005CN1673220A Deoxyneohydroxyaspergillic acid and its prepn and use
09/28/2005CN1220683C Acyl derivatives for treating VLA-4 related disorders
09/28/2005CN1220682C Heterocycle derivatives inhibiting factor Xa
09/27/2005US6949654 Treating diseases arising from reactive oxygen species and/or excess Zn ions, in particular stroke, Parkinson's disease and Alzheimer's disease.
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/22/2005WO2005087823A1 Organometallic complex structure, process for producing the same and containing the organometallic complex structure, functional membrane, functional composite material, functional structure and adsorption desorption sensor
09/22/2005WO2005087215A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/22/2005WO2005068445A3 Pesticidal heterocyclic dihaloallyl compounds
09/22/2005WO2005056547A3 Quinoxalines useful as inhibitors of protein kinases
09/22/2005WO2005016876A3 Cyclic amine bace-1 inhibitors having a benzamide substituent
09/22/2005WO2005004802A3 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
09/22/2005US20050209241 Benzoyl-piperazine derivatives
09/22/2005US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline
09/22/2005CA2558249A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
09/21/2005EP1575942A1 Novel compounds having selective inhibiting efect at gsk3
09/21/2005EP1575939A1 Novel compounds having selective inhibiting effect at gsk3
09/21/2005EP1575919A1 Phenyl or heteroaryl amino alkane derivatives as ip receptor antagonist
09/21/2005EP1575918A2 Substituted biaryl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
09/21/2005EP1377560B1 Piperazine derivatives as tachykinin antagonists
1 ... 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 ... 187